The Patent Finder

Neorx Corporation

Also on record
Records under this name other than patents Neorx Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Neorx Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,515,009Therapeutic inhibitor of vascular smooth muscle cells
Formerly held
Term ended
Ended no later than Feb 4, 2020 · USPTO record
Term endedEnded no later than Feb 4, 2020USPTO record
US 6,117,551Carbon fiber prepreg, and a production process thereof
Formerly held
Term ended
Term ended Aug 11, 2018 · USPTO record
Term endedTerm ended Aug 11, 2018USPTO record
US 6,251,920Prevention and treatment of cardiovascular pathologies
Formerly held
Term ended
Term ended May 21, 2018 · USPTO record
Term endedTerm ended May 21, 2018USPTO record
US 6,989,435Compounds and methods to inhibit or augment an inflammatory response
Formerly held
Lapsed on the fee record
Ended Jan 24, 2018 · USPTO record
Lapsed on the fee recordEnded Jan 24, 2018USPTO record
US 6,197,789Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
Formerly held
Term ended
Term ended Dec 5, 2017 · USPTO record
Term endedTerm ended Dec 5, 2017USPTO record
US 6,166,090Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
Formerly held
Term ended
Term ended Nov 6, 2017 · USPTO record
Term endedTerm ended Nov 6, 2017USPTO record
US 7,605,239Skeletal-targeted radiation to treat bone-associated pathologies
Formerly held
Lapsed on the fee record
Ended Oct 20, 2017 · USPTO record
Lapsed on the fee recordEnded Oct 20, 2017USPTO record
US 8,481,558Compounds to Inhibit or Augment an Inflammatory Response
Lapsed on the fee record
Ended Jul 9, 2017 · Medium confidence
Lapsed on the fee recordEnded Jul 9, 2017Medium confidence
US 7,511,070Compounds and therapies for the prevention of vascular and non-vascular pathologies
Formerly held
Lapsed on the fee record
Ended Mar 31, 2017 · USPTO record
Lapsed on the fee recordEnded Mar 31, 2017USPTO record
US 6,024,937Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
Formerly held
Term ended
Term ended Feb 15, 2017 · USPTO record
Term endedTerm ended Feb 15, 2017USPTO record
10 of 179 patents shown.
Pro members see all 179.
Pro members: see all 179 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited